Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Idan Goren

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
European Journal of Gastroenterology & Hepatology|June 23, 2026
Indirect comparison of endoscopic balloon dilatation, stent placement, and stricturotomy for lower gastrointestinal strictures in Crohn's disease: a systematic review and meta-analysisAbinash Subedi, Abdelkader Chaar, Fatima Keshia Suhail, et al.
Journal of Crohn'S & Colitis|June 30, 2022
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case SeriesBrigida Barberio, Edoardo Savarino, Bram Verstockt, et al.
Journal of Crohn'S & Colitis|August 23, 2024
Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN CohortAnat Yerushalmy-Feler, Rona Lujan, Yiska Loewenberg Weisband, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2020
[¹¹C] choline as a potential PET/CT biomarker of liver cirrhosis: A prospective pilot studyHemda Schmilovitz-Weiss, Doron Boltin, David Groshar, et al.
Annals of Medicine|May 30, 2024
Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world studyJacob E Ollech, Hagar Eran-Banai, Idan Goren, et al.
Therapeutic Advances in Gastroenterology|January 27, 2022
Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseasesHenit Yanai, Bella Ungar, Uri Kopylov, et al.
Journal of Clinical Medicine|December 11, 2022
Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective CohortsIdan Goren, Tali Sharar Fischler, Henit Yanai, et al.
Gut|April 6, 2018
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBDRenaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
European Journal of Gastroenterology & Hepatology|June 23, 2026
Indirect comparison of endoscopic balloon dilatation, stent placement, and stricturotomy for lower gastrointestinal strictures in Crohn's disease: a systematic review and meta-analysisAbinash Subedi, Abdelkader Chaar, Fatima Keshia Suhail, et al.
Journal of Crohn'S & Colitis|June 30, 2022
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case SeriesBrigida Barberio, Edoardo Savarino, Bram Verstockt, et al.
Journal of Crohn'S & Colitis|August 23, 2024
Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN CohortAnat Yerushalmy-Feler, Rona Lujan, Yiska Loewenberg Weisband, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2020
[¹¹C] choline as a potential PET/CT biomarker of liver cirrhosis: A prospective pilot studyHemda Schmilovitz-Weiss, Doron Boltin, David Groshar, et al.
Annals of Medicine|May 30, 2024
Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world studyJacob E Ollech, Hagar Eran-Banai, Idan Goren, et al.
Therapeutic Advances in Gastroenterology|January 27, 2022
Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseasesHenit Yanai, Bella Ungar, Uri Kopylov, et al.
Journal of Clinical Medicine|December 11, 2022
Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective CohortsIdan Goren, Tali Sharar Fischler, Henit Yanai, et al.
Gut|April 6, 2018
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBDRenaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Pageof 7